Abstract
Nickel deficiency leads to reduced iron content in organs and to reduced hemoglobin levels and haematocrit counts. We carried out a clinical trial of oral hyposensitization therapy with low doses of nickel on a group of 20 patients affected by systemic allergy to this sensitizer element and with a chronic relapsing low hemoglobin level and haematocrit count. We obtained interesting results on maintaining these values in treated patients.
MeSH terms
-
Administration, Oral
-
Biomarkers / blood
-
Desensitization, Immunologic* / adverse effects
-
Hematocrit*
-
Hemoglobins / metabolism*
-
Humans
-
Hypersensitivity / blood
-
Hypersensitivity / diagnosis
-
Hypersensitivity / immunology
-
Hypersensitivity / therapy*
-
Maryland
-
Nickel / administration & dosage*
-
Nickel / adverse effects
-
Nickel / immunology*
-
Patch Tests
-
Time Factors
-
Treatment Outcome
Substances
-
Biomarkers
-
Hemoglobins
-
nickel sulfate
-
Nickel